PhD in Pharmaceutical/Medicinal Chemistry

Kunming Medical University (KMU), with roots dating back to 1933 and recognized as a university since 2012, is the leading specialized medical institution in Yunnan province. KMU enrolls around 15,000 students and hosts extensive clinical and research infrastructure through nine affiliated hospitals, multiple teaching and practice sites, and specialized centers for cancer, transplant and dental care. The university emphasizes a blend of clinical training, public health research and medical innovation tailored to regional health needs.

Academically, KMU offers a wide range of undergraduate, master’s and doctoral programs across its 13 schools, supported by more than 1,150 senior academic staff and a large network of research institutes. Laboratories, teaching hospitals and a substantial library collection underpin rigorous training and many provincially and nationally recognized research projects. The university is particularly active in studies of endemic and regional diseases, and it participates in international collaborations and research exchanges with institutions worldwide.

International students have access to an established International Education School, long-standing exchange programs and a variety of accommodation options including double rooms with and without air conditioning and four-bed rooms. KMU provides targeted support for clinical placements, Chinese language learning and professional integration, making it an attractive choice for international learners seeking comprehensive medical education and hands-on hospital experience in a regionally significant center.

The PhD in Pharmaceutical/Medicinal Chemistry at Kunming Medical University is for students who want to learn about creating new medicines. This 3-year PhD program is taught in English and helps students develop skills in chemistry.

Students learn about organic chemistry, medicinal chemistry, and pharmacology. They also get hands-on experience in laboratories and learn how to design and develop new drugs.

After completing this program, students can work as Research Chemists, Pharmaceutical Scientists, or Medicinal Chemists in companies like Pfizer or GlaxoSmithKline. They can also work in universities or government agencies as Professors or Regulatory Affairs Specialists.